Trillium Therapeutics Inc (TRIL) stock is up 2279.41% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TRIL stock a score of 73 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 98. TRIL's rank also includes a long-term technical score of 89. The fundamental score for TRIL is 33. In addition to the average rating from Wall Street analysts, TRIL stock has a mean target price of 8.91. This means analysts expect the stock to rise 10.14% over the next 12 months.
What's Happening with TRIL Stock Today
Trillium Therapeutics Inc (TRIL) stock has risen 10.82% while the S&P 500 is up 0.59% as of 4:00 PM on Tuesday, Jun 30. TRIL is up $0.79 from the previous closing price of $7.30 on volume of 1,738,377 shares. Over the past year the S&P 500 has gained 3.60% while TRIL is up 2279.41%. TRIL earned $2.58 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.14.